CorVel Corp. 10-Q Summary: Period Ended December 31, 2002
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended December 31, 2002, and the nine-month period ended on the same date. CorVel Corporation provides managed care services, primarily in the workers' compensation market, including provider bill review, independent medical examinations (IME), and diagnostic imaging services through its CorCare PPO. The company operates without interest-bearing debt.
Key Financial Metrics
| Metric | Three Months Ended Dec 31, 2002 | Nine Months Ended Dec 31, 2002 |
|---|---|---|
| Revenues | $73.1 million | $208.8 million |
| Net Income | $4.2 million | $12.3 million |
| Earnings Per Share (Diluted) | $0.38 | $1.11 |
| Gross Margin | 17.8% | 18.5% |
| Cash and Equivalents | $8.0 million (as of Dec 31, 2002) | N/A |
| Operating Cash Flow | N/A | $17.6 million |
| Debt | $0 | $0 |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 25% year-over-year for the quarter ($14.4 million increase) and 19% for the nine-month period ($33.7 million increase). Growth was driven by a 45% increase in provider program revenues (bill review, PPO, IME, and MRI services) and the acquisition of AnciCare.
- Profitability: Net income rose 12% for the quarter and 12% for the nine-month period. However, net income margins declined slightly from 6.4% to 5.7% for the quarter due to higher operating expenses.
- Expenses: General and administrative (G&A) expenses increased as a percentage of revenue (from 7.9% to 8.6% for the quarter). This was attributed to increased MIS staffing for new software implementation and a write-off of obsolete capitalized software.
- Liquidity: Cash and cash equivalents decreased from $12.6 million to $8.0 million. Net working capital declined by $1.1 million, primarily due to the AnciCare acquisition and increased accounts receivable.
Outlook, Risks, and Management Commentary
- Acquisitions: The company acquired AnciCare, PPO, Inc. in May 2002 to expand its diagnostic imaging network. Additional contingent payments may be required based on AnciCare's future revenue performance.
- Capital Allocation: The company continues an aggressive share repurchase program. In the nine months ended Dec 31, 2002, it repurchased 1.0 million shares for $10.9 million. Total repurchases since 1996 exceed $80 million.
- Regulatory Risks: The company faces evolving state regulations regarding medical review licensing and managed care networks. Legislative reforms in workers' compensation could impact demand for services.
- Competition: Competition is intensifying from large insurers, HMOs, and PPOs entering the workers' compensation market.
- Forward-Looking Statements: Management cautions that past performance is not indicative of future results and that actual results may differ due to regulatory changes, litigation risks, and market dynamics.
Investor Verification Checklist
- Verify the integration progress and revenue contribution of the AnciCare acquisition.
- Monitor the impact of the write-off of obsolete software on future G&A expense trends.
- Assess the sustainability of the 25% revenue growth rate in the provider program segment.
- Review state-specific regulatory changes affecting medical review licensing requirements.
- Confirm the company's ability to maintain liquidity given the decline in cash balances and continued share repurchases.